Correlation Between Fine Besteel and AptaBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Fine Besteel and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fine Besteel and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fine Besteel Co and AptaBio Therapeutics, you can compare the effects of market volatilities on Fine Besteel and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fine Besteel with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fine Besteel and AptaBio Therapeutics.
Diversification Opportunities for Fine Besteel and AptaBio Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Fine and AptaBio is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Fine Besteel Co and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Fine Besteel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fine Besteel Co are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Fine Besteel i.e., Fine Besteel and AptaBio Therapeutics go up and down completely randomly.
Pair Corralation between Fine Besteel and AptaBio Therapeutics
Assuming the 90 days trading horizon Fine Besteel Co is expected to under-perform the AptaBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Fine Besteel Co is 1.51 times less risky than AptaBio Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The AptaBio Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 1,340,000 in AptaBio Therapeutics on August 24, 2024 and sell it today you would lose (712,000) from holding AptaBio Therapeutics or give up 53.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fine Besteel Co vs. AptaBio Therapeutics
Performance |
| Timeline |
| Fine Besteel |
| AptaBio Therapeutics |
Fine Besteel and AptaBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fine Besteel and AptaBio Therapeutics
The main advantage of trading using opposite Fine Besteel and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fine Besteel position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.| Fine Besteel vs. AptaBio Therapeutics | Fine Besteel vs. Daewoo SBI SPAC | Fine Besteel vs. Dream Security co | Fine Besteel vs. Microfriend |
| AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |